GB9722051D0 - Phytodrug for treatment and management of sickle cell anemia and methods of preparing and using same - Google Patents

Phytodrug for treatment and management of sickle cell anemia and methods of preparing and using same

Info

Publication number
GB9722051D0
GB9722051D0 GBGB9722051.1A GB9722051A GB9722051D0 GB 9722051 D0 GB9722051 D0 GB 9722051D0 GB 9722051 A GB9722051 A GB 9722051A GB 9722051 D0 GB9722051 D0 GB 9722051D0
Authority
GB
United Kingdom
Prior art keywords
phytodrug
management
preparing
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9722051.1A
Other versions
GB2330304A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UNITED NATIONS DEV PROGRAMME
National Institute for Pharmaceutical Research and Development
Original Assignee
UNITED NATIONS DEV PROGRAMME
National Institute for Pharmaceutical Research and Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US08/786,313 priority Critical patent/US5800819A/en
Priority claimed from ZA9708662A external-priority patent/ZA978662B/en
Priority to ZA9708662A priority patent/ZA978662B/en
Priority to DE19745712A priority patent/DE19745712A1/en
Priority to GB9722051A priority patent/GB2330304A/en
Application filed by UNITED NATIONS DEV PROGRAMME, National Institute for Pharmaceutical Research and Development filed Critical UNITED NATIONS DEV PROGRAMME
Priority to FR9713437A priority patent/FR2770133A1/en
Priority to CN97122296A priority patent/CN1217206A/en
Publication of GB9722051D0 publication Critical patent/GB9722051D0/en
Priority to APAP/P/1998/001207A priority patent/AP892A/en
Priority to JP10101665A priority patent/JP3053608B2/en
Publication of GB2330304A publication Critical patent/GB2330304A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
GB9722051A 1996-01-25 1997-10-17 Pharmaceutical composition for the treatment of sickle cell disease Withdrawn GB2330304A (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US08/786,313 US5800819A (en) 1996-01-25 1997-01-21 Piper guineense, pterocarpus osun, eugenia caryophyllata, and sorghum bicolor extracts for treating sickle cell disease
ZA9708662A ZA978662B (en) 1996-01-25 1997-09-26 Phytodrug for treatment and management of sickle cell anaemia and methods of preparing and using same.
DE19745712A DE19745712A1 (en) 1996-01-25 1997-10-16 New composition for treating sickle cell disease
GB9722051A GB2330304A (en) 1996-01-25 1997-10-17 Pharmaceutical composition for the treatment of sickle cell disease
FR9713437A FR2770133A1 (en) 1996-01-25 1997-10-27 New composition for treating sickle cell disease
CN97122296A CN1217206A (en) 1996-01-25 1997-11-13 Phytodrug for treatment and management of sickle cell anemia and method of preparing and using same
APAP/P/1998/001207A AP892A (en) 1996-01-25 1998-01-05 Niprisan-phytodrug for treatment and management of sickle cell anaemia and methods of preparing and using same.
JP10101665A JP3053608B2 (en) 1996-01-25 1998-03-11 Herbal medicine for the treatment and management of sickle cell anemia, its production and use

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
NG1236996 1996-01-25
ZA9708662A ZA978662B (en) 1996-01-25 1997-09-26 Phytodrug for treatment and management of sickle cell anaemia and methods of preparing and using same.
DE19745712A DE19745712A1 (en) 1996-01-25 1997-10-16 New composition for treating sickle cell disease
GB9722051A GB2330304A (en) 1996-01-25 1997-10-17 Pharmaceutical composition for the treatment of sickle cell disease
FR9713437A FR2770133A1 (en) 1996-01-25 1997-10-27 New composition for treating sickle cell disease
CN97122296A CN1217206A (en) 1996-01-25 1997-11-13 Phytodrug for treatment and management of sickle cell anemia and method of preparing and using same
APAP/P/1998/001207A AP892A (en) 1996-01-25 1998-01-05 Niprisan-phytodrug for treatment and management of sickle cell anaemia and methods of preparing and using same.
JP10101665A JP3053608B2 (en) 1996-01-25 1998-03-11 Herbal medicine for the treatment and management of sickle cell anemia, its production and use

Publications (2)

Publication Number Publication Date
GB9722051D0 true GB9722051D0 (en) 1997-12-17
GB2330304A GB2330304A (en) 1999-04-21

Family

ID=33437312

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9722051A Withdrawn GB2330304A (en) 1996-01-25 1997-10-17 Pharmaceutical composition for the treatment of sickle cell disease

Country Status (7)

Country Link
US (1) US5800819A (en)
JP (1) JP3053608B2 (en)
CN (1) CN1217206A (en)
AP (1) AP892A (en)
DE (1) DE19745712A1 (en)
FR (1) FR2770133A1 (en)
GB (1) GB2330304A (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800819A (en) * 1996-01-25 1998-09-01 National Institute For Pharmaceutical Research And Development Federal Ministry Of Science And Technology Piper guineense, pterocarpus osun, eugenia caryophyllata, and sorghum bicolor extracts for treating sickle cell disease
US6105991A (en) 1997-11-20 2000-08-22 The Burton Corporation Core for a gliding board
ES2434946T3 (en) 2005-08-31 2013-12-18 Celgene Corporation Isoindol imide compounds and compositions comprising them and methods for using it
US8877780B2 (en) 2006-08-30 2014-11-04 Celgene Corporation 5-substituted isoindoline compounds
WO2008039489A2 (en) 2006-09-26 2008-04-03 Celgene Corporation 5-substituted quinazolinone derivatives as antitumor agents
ZA200902382B (en) 2006-10-19 2010-08-25 Signal Pharm Llc Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors
ES2442257T3 (en) 2006-10-27 2014-02-10 Signal Pharmaceuticals Llc Solid forms comprising 4- [9- (tetrahydro-furan-3-yl) -8- (2,4,6-trifluoro-phenylamino) -9H-purin-2-ylamino] -cyclohexan-1-ol, its compositions and its uses
KR20090121400A (en) 2007-03-20 2009-11-25 셀진 코포레이션 4'-o-substituted isoindoline derivatives and compositions comprising and methods of using the same
US8895075B2 (en) * 2007-09-20 2014-11-25 Atul M. Desai Herbomineral formulation for treating sickle cell disease
MY157495A (en) 2007-09-26 2016-06-15 Celgene Corp 6-,7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same
US20090298882A1 (en) * 2008-05-13 2009-12-03 Muller George W Thioxoisoindoline compounds and compositions comprising and methods of using the same
US8110578B2 (en) 2008-10-27 2012-02-07 Signal Pharmaceuticals, Llc Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
KR101696938B1 (en) 2008-10-29 2017-01-16 셀진 코포레이션 Isoindoline compounds for use in the treatment of cancer
WO2010093434A1 (en) 2009-02-11 2010-08-19 Celgene Corporation Isotopologues of lenalidomide
US20100255132A1 (en) * 2009-04-06 2010-10-07 Swami Nathan Novel botanical formulation for treating sickle cell disease
AU2010249615B2 (en) 2009-05-19 2013-07-18 Celgene Corporation Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione
WO2011079091A1 (en) 2009-12-22 2011-06-30 Celgene Corporation (methylsulfonyl) ethyl benzene isoindoline derivatives and their therapeutical uses
SI3202461T1 (en) 2010-02-11 2019-05-31 Celgene Corporation Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same
US8603527B2 (en) 2010-10-25 2013-12-10 Signal Pharmaceuticals, Llc Pharmaceutical formulations of a substituted diaminopurine
EP2663549B1 (en) 2011-01-10 2018-03-14 Celgene Corporation Phenethylsulfone isoindoline derivatives as inhibitors of pde 4 and/or cytokines
US9045417B2 (en) 2011-01-14 2015-06-02 Celgene Corporation Isotopologues of isoindole derivatives
DK2683708T3 (en) 2011-03-11 2018-01-29 Celgene Corp SOLID FORMS OF 3- (5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL) -PIPERIDIN-2,6-DION AND PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS THEREOF
US20140221427A1 (en) 2011-06-22 2014-08-07 Celgene Corporation Isotopologues of pomalidomide
AU2012308663B2 (en) 2011-09-14 2017-06-08 Amgen (Europe) GmbH Formulations of cyclopropanecarboxylic acid {2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}-amide
AU2012362562B2 (en) 2011-12-27 2017-11-02 Amgen (Europe) GmbH Formulations of (+)-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-4-acetyl aminoisoindoline-1,3-dione
ES2885769T3 (en) 2012-08-09 2021-12-15 Celgene Corp A solid form of (s) -3- (4 - ((4-morpholinomethyl) benzyl) oxy) -1-oxoisoindolin-2-yl) piperidine-2,6-dione hydrochloride
EP2943201B2 (en) 2013-01-14 2020-07-29 Deuterx, LLC 3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
EP2764866A1 (en) 2013-02-07 2014-08-13 IP Gesellschaft für Management mbH Inhibitors of nedd8-activating enzyme
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern
UA117141C2 (en) 2013-10-08 2018-06-25 Селджин Корпорейшн Formulations of (s)-3-(4-((4-(morpholinomethyl)benzyloxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione
US20150196562A1 (en) 2014-01-15 2015-07-16 Celgene Corporation Formulations of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione
BR112018014926A2 (en) * 2016-01-23 2018-12-18 Gyan Bhansali Anil composition for treating sickle cell anemia, composition for preparing an effective drug for treating sickle cell anemia, method for preparing a composition for treating sickle cell anemia and method for treating a human suffering from sickle cell anemia
WO2018013693A1 (en) 2016-07-13 2018-01-18 Celgene Corporation Solid dispersions and cocrystals comprising 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione compositions and methods of use thereof
WO2018013689A1 (en) 2016-07-13 2018-01-18 Celgene Corporation Solid dispersions and solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, method of preparation and use thereof
CN117242088A (en) 2020-08-05 2023-12-15 辛德凯因股份有限公司 IL10 receptor binding molecules and methods of use
EP4192877A4 (en) 2020-08-05 2024-10-16 Synthekine Inc Il2rb/il2rg synthetic cytokines
JP2024504923A (en) 2021-01-11 2024-02-02 シンセカイン インコーポレイテッド Compositions and methods for receptor pairing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473559A (en) * 1981-08-13 1984-09-25 Robinson Larry H Method and composition for retarding red blood cell sickling
FR2588475B1 (en) * 1985-10-11 1988-01-08 Marcel Fitoussi MODERATOR OF HUNGER SENSATION AND THE SMOKING FANTASY BY INHALATION OF EUGENIA CARYOPHYLLATA
US5225447A (en) * 1988-03-28 1993-07-06 Omex International, Inc. Composition and method for the treatment of sickle cell anemia
US5447720A (en) * 1993-07-06 1995-09-05 Sunday O. Fadulu Composition and method for treatment of hemoglobinopathies
US5449516A (en) * 1993-08-12 1995-09-12 Instituto De Medicina Tropical De Sao Paulo Brazilian ginseng derivatives for treatment of sickle cell symptomatology
US5800819A (en) * 1996-01-25 1998-09-01 National Institute For Pharmaceutical Research And Development Federal Ministry Of Science And Technology Piper guineense, pterocarpus osun, eugenia caryophyllata, and sorghum bicolor extracts for treating sickle cell disease

Also Published As

Publication number Publication date
US5800819A (en) 1998-09-01
JPH11292779A (en) 1999-10-26
FR2770133A1 (en) 1999-04-30
DE19745712A1 (en) 1999-04-22
AP9801207A0 (en) 1998-03-31
AP892A (en) 2000-11-16
GB2330304A (en) 1999-04-21
CN1217206A (en) 1999-05-26
JP3053608B2 (en) 2000-06-19

Similar Documents

Publication Publication Date Title
GB9722051D0 (en) Phytodrug for treatment and management of sickle cell anemia and methods of preparing and using same
AU2650795A (en) Methods and apparatus for cryopreservation of cells
EP0824316A4 (en) Compositions and methods for stimulating hair growth
AU5849896A (en) Improved investment and account management system
PL332547A1 (en) Skin care compositions containing an acid and retinoide
IL129195A0 (en) Method of preparing lithium salts
AU6872498A (en) Method and composition for skin treatment
HK1019312A1 (en) Skin battery cosmetic composition
AU7752694A (en) Method for preventing hair loss and stimulating new hair growth
AU3768795A (en) Method and compositions for hair treatment
AU9585798A (en) Method and system for pain management
AU3127795A (en) Composition and treatment for baldness
AU5970496A (en) Compounds and methods for promoting hair growth
AU3539095A (en) Hair transplantation apparatus and methods
AUPM424894A0 (en) Treatment of electrolyte solutions
AU2992295A (en) Therapeutic method and compounds of use therein
ZA978662B (en) Phytodrug for treatment and management of sickle cell anaemia and methods of preparing and using same.
AU7104694A (en) Compounds and methods for treating sickle cell anemia
AU2966695A (en) Method and compound for the treatment of hair loss
AU4315997A (en) Mammalian and human rec2
ZA955409B (en) Keratolytic-wound healing compositions and methods for preparing and using same
AU698906C (en) Methods and compositions for stimulating bone cells
MD860B2 (en) Osseous transplant and method for preparation thereof
AU3423397A (en) Therapeutic methods and compositions for use therein
ZA952911B (en) Antiviral-wound healing compositions and methods for preparing and using same

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)